BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of September 17, 2026, BRTX trades at $2.60 with a market cap of $3.73M and a P/E ratio of -1.67. BRTX moved +0.00% today. Year to date, BRTX is -88.77%; over the trailing twelve months it is -91.26%. Its 52-week range spans $2.61 to $51.00. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for BRTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.60 |
| Market Cap | $3.73M |
| P/E Ratio | -1.67 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $51.00 |
| 52-Week Low | $2.61 |
| Volume | 10.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $359.70K |
| Net Income | $-14.24M |
| Gross Margin | 93.37% |
BRTX analyst coverage data. Average price target: $0.00.